Crosignani P - Search Results

1

Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial.

Meschia M, Bruschi F, Soma M, Amicarelli F, Paoletti R, Crosignani P. Meschia M, et al. Among authors: crosignani p. Menopause. 1998 Fall;5(3):157-62. Menopause. 1998. PMID: 9774761 Clinical Trial.

2

Hormonal agents used in lowering lipoprotein(a).

Soma MR, Meschia M, Bruschi F, Morrisett JD, Paoletti R, Fumagalli R, Crosignani P. Soma MR, et al. Among authors: crosignani p. Chem Phys Lipids. 1994 Jan;67-68:345-50. doi: 10.1016/0009-3084(94)90156-2. Chem Phys Lipids. 1994. PMID: 8187233 Clinical Trial.

3

Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy.

Bruschi F, Meschia M, Soma M, Perotti D, Paoletti R, Crosignani PG. Bruschi F, et al. Among authors: crosignani pg. Obstet Gynecol. 1996 Dec;88(6):950-4. doi: 10.1016/s0029-7844(96)00349-3. Obstet Gynecol. 1996. PMID: 8942833

4

Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial.

Bruschi F, Dal Pino D, Fiore V, Parazzini F, Di Pace R, Cesana BM, Melotti D, Crosignani PG. Bruschi F, et al. Among authors: crosignani pg. Maturitas. 2004 May 28;48(1):33-8. doi: 10.1016/j.maturitas.2003.08.005. Maturitas. 2004. PMID: 15223106 Clinical Trial.

5

Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women.

Poli A, Bruschi F, Cesana B, Rossi M, Paoletti R, Crosignani PG. Poli A, et al. Obstet Gynecol. 2003 Nov;102(5 Pt 1):922-6. doi: 10.1016/j.obstetgynecol.2003.07.004. Obstet Gynecol. 2003. PMID: 14672464

6

The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women.

Soma MR, Osnago-Gadda I, Paoletti R, Fumagalli R, Morrisett JD, Meschia M, Crosignani P. Soma MR, et al. Among authors: crosignani p. Arch Intern Med. 1993 Jun 28;153(12):1462-8. Arch Intern Med. 1993. PMID: 8390232 Clinical Trial.

7

Sustained prolactin release associated with precocious ovarian failure.

Crosignani PG, Meschia M, Bruschi F, Parazzini F. Crosignani PG, et al. Gynecol Obstet Invest. 1995;39(1):63-4. doi: 10.1159/000292379. Gynecol Obstet Invest. 1995. PMID: 7890257

8

Gonadotrophins and prolactin rise after bilateral oophorectomy for benign conditions.

Crosignani PG, Meschia M, Bruschi F, Amicarelli F, Parazzini F. Crosignani PG, et al. Hum Reprod. 1995 Sep;10(9):2277-9. doi: 10.1093/oxfordjournals.humrep.a136284. Hum Reprod. 1995. PMID: 8530651

9

Hormone replacement and the menopause: a European position paper. Writing Group on Women's Health of the Fondazione Giovanni Lorenzini Medical Science Foundation.

Crosignani PG, Kenemans P, Paoletti R, Soma MR, Woodford FP. Crosignani PG, et al. Eur J Obstet Gynecol Reprod Biol. 1997 Jul;74(1):67-72. doi: 10.1016/s0301-2115(97)02744-9. Eur J Obstet Gynecol Reprod Biol. 1997. PMID: 9243206 Review. No abstract available.

10

Effect of hormone replacement therapy and calcitonin on bone mass in postmenopausal women.

Meschia M, Brincat M, Barbacini P, Maini MC, Marri R, Crosignani PG. Meschia M, et al. Among authors: crosignani pg. Eur J Obstet Gynecol Reprod Biol. 1992 Oct 23;47(1):53-7. doi: 10.1016/0028-2243(92)90214-j. Eur J Obstet Gynecol Reprod Biol. 1992. PMID: 1330761 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

493 results

Search Page

Filters